Benzotropolone derivatives and modulation of inflammatory response
CA 2536842 C · Owner: Rutgers, The State University Of New Jersey · Inventors: Ghai, Geetha; Dushenkov, Slavik; Ho, Chi-Tang
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides novel benzotropolone derivatives represented by the general formula: including neotheaflavate B and EGCGCa. The benzotropolone derivatives of the present invention are effective antioxidant and antiinflammatory agents. The present invention also provides novel method of synthesizing benzotropolone compounds in high yields and method of treating inflammatory conditions using benzotropolone containing compounds.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 30, 2004 and granted October 7, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 30, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 30, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.